Bloomage BioTechnology Corporation Limited (688363.SS)
CNY 47.55
(-0.46%)
CNY 47.55
(-0.46%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 215.3 Million CNY | -44.76% |
| 2022 | 389.78 Million CNY | 29.92% |
| 2021 | 300.01 Million CNY | 1146.17% |
| 2020 | 24.07 Million CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 40 Million CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 220 Million CNY | -74.16% |
| 2015 | 851.28 Million CNY | 1487.35% |
| 2014 | 53.62 Million CNY | -40.83% |
| 2013 | 90.63 Million CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 92.85 Million CNY | 28.04% |
| 2024 Q1 | 106.14 Million CNY | -50.7% |
| 2024 Q2 | 209.26 Million CNY | 97.15% |
| 2023 Q3 | 198.8 Million CNY | 1.17% |
| 2023 FY | 215.3 Million CNY | -44.76% |
| 2023 Q2 | 196.49 Million CNY | -42.39% |
| 2023 Q1 | 341.07 Million CNY | -12.5% |
| 2023 Q4 | 215.3 Million CNY | 8.3% |
| 2022 Q3 | 396.53 Million CNY | 0.86% |
| 2022 Q2 | 393.15 Million CNY | 43.7% |
| 2022 Q1 | 273.58 Million CNY | -8.81% |
| 2022 FY | 389.78 Million CNY | 29.92% |
| 2022 Q4 | 389.78 Million CNY | -1.7% |
| 2021 Q1 | 258.81 Million CNY | 975.04% |
| 2021 Q3 | 288.02 Million CNY | 3.39% |
| 2021 Q4 | 300.01 Million CNY | 4.16% |
| 2021 FY | 300.01 Million CNY | 1146.17% |
| 2021 Q2 | 278.58 Million CNY | 7.64% |
| 2020 Q2 | 23.87 Million CNY | 0.0% |
| 2020 FY | 24.07 Million CNY | 0.0% |
| 2020 Q3 | 23.98 Million CNY | 0.43% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q4 | 24.07 Million CNY | 0.39% |
| 2019 FY | - CNY | -100.0% |
| 2019 Q1 | 40 Million CNY | 0.0% |
| 2019 Q2 | 40 Million CNY | 0.0% |
| 2019 Q3 | 40 Million CNY | 0.0% |
| 2019 Q4 | - CNY | -100.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 40 Million CNY | 0.0% |
| 2018 Q4 | 40 Million CNY | 0.0% |
| 2017 Q1 | 648 Million CNY | -14.47% |
| 2017 Q2 | 648 Million CNY | 0.0% |
| 2017 FY | - CNY | -100.0% |
| 2016 Q2 | 618.66 Million CNY | 0.0% |
| 2016 Q4 | 757.66 Million CNY | 0.0% |
| 2016 Q3 | 757.66 Million CNY | 22.47% |
| 2016 Q1 | 618.66 Million CNY | -27.33% |
| 2016 FY | 220 Million CNY | -74.16% |
| 2015 Q2 | 267.61 Million CNY | 0.0% |
| 2015 Q3 | 851.28 Million CNY | 218.11% |
| 2015 Q4 | 851.28 Million CNY | 0.0% |
| 2015 Q1 | 267.61 Million CNY | 399.0% |
| 2015 FY | 851.28 Million CNY | 1487.35% |
| 2014 FY | 53.62 Million CNY | -40.83% |
| 2014 Q3 | 53.62 Million CNY | 9.11% |
| 2014 Q1 | 49.15 Million CNY | -45.77% |
| 2014 Q2 | 49.15 Million CNY | 0.0% |
| 2014 Q4 | 53.62 Million CNY | 0.0% |
| 2013 FY | 90.63 Million CNY | 0.0% |
| 2013 Q2 | 86.07 Million CNY | 0.0% |
| 2013 Q1 | 86.07 Million CNY | 0.0% |
| 2013 Q4 | 90.63 Million CNY | 0.0% |
| 2013 Q3 | 90.63 Million CNY | 5.3% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |